ReviewJournal of Cancer2019

Eribulin in Triple Negative Metastatic Breast Cancer: Critic Interpretation of Current Evidence and Projection for Future Scenarios.

Laura Pizzuti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.